210 related articles for article (PubMed ID: 2903953)
41. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.
Krown SE; Real FX; Cunningham-Rundles S; Myskowski PL; Koziner B; Fein S; Mittelman A; Oettgen HF; Safai B
N Engl J Med; 1983 May; 308(18):1071-6. PubMed ID: 6835320
[No Abstract] [Full Text] [Related]
42. Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors.
Krown SE; Real FX; Vadhan-Raj S; Cunningham-Rundles S; Krim M; Wong G; Oettgen HF
Cancer; 1986 Apr; 57(8 Suppl):1662-5. PubMed ID: 3081247
[TBL] [Abstract][Full Text] [Related]
43. [Efficiency of combination chemotherapy and interferon-alpha therapy in a patient with AIDS-related cutaneous and gastrointestinal Kaposi's sarcoma].
Sawayama Y; Hayashi J; Yano Y; Takeya S; Tani Y; Pei Y; Kashiwagi S
Kansenshogaku Zasshi; 1996 Jun; 70(6):621-6. PubMed ID: 8741713
[TBL] [Abstract][Full Text] [Related]
44. Successful treatment of Kaposi's sarcoma with interferon-alpha in a patient with acquired immunodeficiency syndrome.
Yeh TS; Wang CR; Wong WW; Jeng GW; Chen MY; Liu CY; Chuang CY; Chen WY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1993 Feb; 26(1):38-43. PubMed ID: 7907542
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous local necrosis following interferon injections.
Cnudde F; Gharakhanian S; Luboinski J; Dry J; Rozenbaum W
Int J Dermatol; 1991 Feb; 30(2):147. PubMed ID: 2001907
[No Abstract] [Full Text] [Related]
46. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
47. [Therapy of AIDS-induced Kaposi sarcoma and malignant melanoma with interferons].
Stadler R; Bratzke B; Mayer da Silva A; Orfanos CE
Onkologie; 1988 Aug; 11(4):166-76. PubMed ID: 3054668
[TBL] [Abstract][Full Text] [Related]
48. [Haemolytic uremic syndrome and acute mesenteric ischemia caused by interferon-alpha-2b in the treatment of Kaposi's sarcoma in an AIDS patient].
Zaraa I; Maubec E; Valeyrie-Allanore L; Essig M; Charachon A; Chosidow D; Debray MP; Marinho E; Picard-Dahan C; Descamps V; Crickx B
Ann Dermatol Venereol; 2007 Jan; 134(1):65-7. PubMed ID: 17384548
[TBL] [Abstract][Full Text] [Related]
49. Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpesvirus-8.
Deichmann M; Thome M; Jäckel A; Utermann S; Bock M; Waldmann V; Näher H
Br J Dermatol; 1998 Dec; 139(6):1052-4. PubMed ID: 9990371
[TBL] [Abstract][Full Text] [Related]
50. Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS; Rarick MU; Bernstein-Singer M; Espina BM; Jones B; Montgomery T; Sharma D; Rasheed S; Levine AM
J Biol Response Mod; 1990 Oct; 9(5):512-6. PubMed ID: 2254762
[TBL] [Abstract][Full Text] [Related]
51. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma.
Abrams DI; Volberding PA
Semin Oncol; 1987 Jun; 14(2 Suppl 2):43-7. PubMed ID: 3589704
[TBL] [Abstract][Full Text] [Related]
52. A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies.
Reiter Z; Ozés ON; Blatt LM; Sturzl M; Taylor MW
J Acquir Immune Defic Syndr (1988); 1992; 5(5):469-76. PubMed ID: 1560343
[TBL] [Abstract][Full Text] [Related]
53. Alpha interferon approved for AIDS-related Kaposi's sarcoma.
Oncology (Williston Park); 1989 Jan; 3(1):105. PubMed ID: 2641303
[No Abstract] [Full Text] [Related]
54. Biotherapy with interferon in AIDS-related Kaposi's sarcoma.
Mitsuyasu RT; Miles SA
Oncol Nurs Forum; 1987; 14(6 Suppl):27-31. PubMed ID: 3320983
[No Abstract] [Full Text] [Related]
55. Alpha interferon therapy of AIDS-associated Kaposi's sarcoma.
Abrams DI; Volberding PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):43-7. PubMed ID: 3532335
[TBL] [Abstract][Full Text] [Related]
56. Ocular pseudo-myasthenic reaction induced by interferon in an AIDS patient.
Riedel RR; Schmitt A; Hartmann A
Klin Wochenschr; 1991 Dec; 69(20):930-1. PubMed ID: 1795499
[TBL] [Abstract][Full Text] [Related]
57. Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A).
Volberding PA; Mitsuyasu RT; Golando JP; Spiegel RJ
Cancer; 1987 Feb; 59(3 Suppl):620-5. PubMed ID: 3492260
[TBL] [Abstract][Full Text] [Related]
58. [Aseptic skin necrosis after subcutaneous injection of alpha interferon].
Rasokat H; Bendick C; Wemmer U; Steigleder GK
Dtsch Med Wochenschr; 1989 Mar; 114(12):458-60. PubMed ID: 2924699
[TBL] [Abstract][Full Text] [Related]
59. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
60. Complete regression of laryngeal involvement by classic Kaposi's sarcoma with low-dose alpha-2b interferon.
Gridelli C; Palmieri G; Airoma G; Incoronato P; Pepe R; Barra E; Bianco AR
Tumori; 1990 Jun; 76(3):292-3. PubMed ID: 2368177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
